Risks, Benefits, and the Optimal Time to Resume Deep Vein Thrombosis Prophylaxis in Patients with Intracranial Hemorrhage

Introduction It is common to start all patients on chemical prophylaxis for deep vein thrombosis (DVT) in order to decrease the risk of venous thromboembolism (VTE) and the associated adverse effects, including the potential for fatal pulmonary embolism (PE). There is no consensus in the literature...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cureus
Prif Awduron: Farr, Saman, Toor, Harjyot, Patchana, Tye, Podkovik, Stacey, Wiginton, James G, Sweiss, Raed, Wacker, Margaret Rose, Miulli, Dan E
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Cureus 2019
Pynciau:
Quality Improvement
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6827698/
https://ncbi.nlm.nih.gov/pubmed/31754562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.5827
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg